Fennec Pharmaceuticals is trading 5.46% down at $10.94, with no clear company-specific negative announcement identified for August 10, 2026.
- Second-quarter 2026 results are scheduled before market open on August 11.
- The conference call is scheduled for 8:30 a.m. Eastern Time.
- The decline follows a strong recent run, while broader markets are roughly mixed rather than sharply lower.